Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever

Vaccine

Volumn 18, Issue 11-12, 2000, Pages 1040-1050

  Hammond, Jef M ^a   McCoy, Richard J ^a   Jansen, Elisa S ^a   Morrissy, Christopher J ^a   Hodgson, Adrian L M ^a   Johnson, Michael A ^a  

^a CSIRO   (Australia)

Author keywords

Adenovirus; Recombinant; Vaccine

Indexed keywords

RECOMBINANT VACCINE; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PESTIVIRUS; PRIORITY JOURNAL; SWINE DISEASE; VACCINATION; VIRUS GENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER VIRUS; RECOMBINANT PROTEINS; SWINE; VACCINATION; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0033990732     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00347-3     Document Type: Article

References (38)

1. Shenk T. Adenoviridae: the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. 3:1996;Lippincott-Raven publishers, Philadelphia.
2. Benko M., Harrach B. A proposal for a new (third) genus within the family Adenoviridae. Arch. Virol. 143:1998;829-837.
3. Grunhaus A., Horwitz M.S. Adenoviruses as cloning vectors. Semin. Virology. 3:1992;237-252.
4. Kovesdi I., Brough D.E., Bruder J.T., Wickham T.J. Adenoviral vectors for gene transfer. Curr. Opin. Biotechnol. 8:1997;583-589.
5. Mittal S.K., Prevec L., Graham F.L., Babiuk L.A. Development of a bovine adenovirus type 3-based expression vector. J. Gen. Virol. 76:1995;93-102.
6. Xu Z.Z., Hyatt A., Boyle D.B., Both G.W. Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences. Virology. 230:1997;62-71.
7. Klonjkowski B., Gilardi-Hebenstreit P., Hadchouel J., Randrianarison V., Boutin S., Yeh P., Perricaudet M., Kremer E.J. A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo. Hum. Gene. Ther. 8:1997;2103-2115.
8. Sheppard M., Werner W., Tsatas E., McCoy R., Prowse S., Johnson M. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Arch. Virol. 143:1998;915-930.
9. Derbyshire J.B., Clarke M.C., Collins A.P. Serological and pathogenicity studies with some unclassified porcine adenoviruses. J. Comp. Pathol. 85:1975;437-443.
10. Hirahara T., Yasuhara H., Matsui O., Yamanaka M., Tanaka M., Fukuyama S., Izumida A., Yoshiki K., Kodama K., Nakai M., Sasaki N. Isolation of porcine adenovirus from the respiratory tract of pigs in Japan. Nippon Juigaku Zasshi. 52:1990;407-409.
11. Tuboly T., Reddy P.S., Nagy E., Derbyshire J.B. Restriction endonuclease analysis and physical mapping of the genome of porcine adenovirus type 5. Virus Res. 37:1995;49-54.
12. Barker I.K., Van Dreumel A.A., Palmer N. Porcine adenovirus. Jubb K.V.F., Kennedy P.C., Palmer N. Pathology of domestic animals, 4th ed. 2:1993;182-183 Academic Press, London.
13. Torres J.M., Alonso C., Ortega A., Mittal S., Graham F., Enjuanes L. Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. J. Virol. 70:1996;3770-3780.
14. Pringle C.R. The universal system of virus taxonomy of the International Committee on Virus Taxonomy (ICTV), including new proposals ratified since publication of the Sixth ICTV Report in 1995. Arch. Virol. 143:1998;203-210.
15. Dahle J., Liess B. A review on classical swine fever infections in pigs: epizootiology, clinical disease and pathology. Comp. Immunol. Microbiol. Infect. Dis. 15:1992;203-211.
16. König M., Lengsfeld T., Pauly T., Stark R., Thiel H.J. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J. Virol. 69:1995;6479-6486.
17. Van Zijl M., Wensvoort G., de Kluyver E., Hulst M., Van der Gulden H., Gielkens A., Berns A., Moormann R. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J. Virol. 65:1991;2761-2765.
18. Peeters B., Bienkowska-Szewczyk K., Hulst M., Gielkens A., Kimman T. Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszkys disease and classical swine fever. J. Gen. Virol. 78:1997;3311-3315.
19. Hulst M.M., Westra D.F., Wensvoort G., Moormann R.J. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Virol. 67:1993;5435-5442.
20. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 14:1967;365-369.
21. Shinagawa M., Matsuda A., Ishiyama T., Goto H., Sato G. A rapid and simple method for preparation of adenovirus DNA from infected cells. Microbiol. Immunol. 27:1983;817-822.
22. Sambrook J., Fritsch E.F., Maniatis T. Nolan C. Molecular Cloning; a laboratory manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
23. McCoy R.J., Johnson M.A., Studdert M.J., Sheppard M. Genomic location and nucleotide sequence of a porcine adenovirus penton base gene. Arch. Virol. 141:1996;1367-1375.
24. Reddy P.S., Nagy E., Derbyshire J.B. Restriction endonuclease analysis and molecular cloning of porcine adenovirus type 3. Intervirol. 36:1993;161-168.
25. Kleiboeker S.B., Seal B.S., Mengeling W.L. Genomic cloning and restriction site mapping of a porcine adenovirus isolate: demonstration of genomic stability in porcine adenovirus. Arch. Virol. 133:1993;357368.
26. Ziff E.B., Evans R.M. Coincidence of the promoter and capped 5′ terminus of RNA from the adenovirus 2 major late transcription unit. Cell. 15:1978;1463-1476.
27. Reddy P.S., Idamakanti N., Song J.Y., Lee J.B., Hyun B.H., Park J.H., Cha S.H., Bae Y.T., Tikoo S.K., Babiuk L.A. Nucleotide sequence and transcription map of porcine adenovirus type 3. Virology. 251:1998;414-426.
28. Yu M., McColl A., Gould A.R. Cloning and nucleotide sequence determination of the major envelope glycoprotein (gp55) gene of hog cholera virus (Weybridge). Virus Res. 28:1993;203-208.
29. Kärber G. 50% end point calculation. Arch. Pathol. Pharmakol. 162:1931;480-483.
30. Precausta P., Kato F., Vellut G. A new freeze-dried living virus vaccine against sheep-pox. Comp. Immunol. Microbiol. Infect. Dis. 1:1979;305-319.
31. Terpstra C., Bloemraad M., Gielkens A.J.L. The neutralising peroxidase-linked assay for detection of antibody against swine fever virus. Vet. Microbiol. 9:1984;113-120.
32. Terpstra C., Wensvoort G. The protective value of vaccine-induced neutralising antibody titres in swine fever. Vet. Microbiol. 16:1988;123-128.
33. Van Rijn P.A., Bossers A., Wensvoort G., Moormann R.J. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J. Gen. Virol. 77:1996;2737-2745.
34. Van Bekkum J.G. Serological aspects of the vaccination against hog cholera with crystal violet vaccine. Tijdschr. Diergeneeskd. 91:1966;149-170.
35. Kimman T.G., Bianchi A.T., Wensvoort G., de Bruin T.G., Meliefste C. Cellular immune response to hog cholera virus (HCV): T cells of immune pigs proliferate in vitro upon stimulation with live HCV, but the E1 envelope glycoprotein is not a major T-cell antigen. J. Virol. 67:1993;2922-2927.
36. Adair B.M., McFerran J.B. Comparative serological studies with mammalian adenoviruses. Arch. Virol. 51:1976;319-325.
37. Bett A.J., Prevec L., Graham F.L. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67:1993;5911-5921.
38. Parks R.J., Graham F.L. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J. Virol. 71:1997;3293-3298.